The COVID-19 crisis highlighted the importance of vaccines and demonstrated a need for effective and scalable training to ensure a well-trained workforce to meet global vaccine demand.
MIT, Merck, Quincy College, and Sanofi have teamed up to develop an integrated, modular, and scalable workforce training program. This educational content will be suitable for training new hires, reskilling workers already familiar with biopharmaceutical manufacturing, and providing targeted and specific context to individuals in support roles.
The content will be comprised of both online and hands-on components.
Online – six individual modules:
Hands-on – two training modules:
OUTPUTS
Coming Soon
The development of an integrated and modular program will strengthen the pipeline of qualified candidates for vaccine manufacturing by providing the industry with standardized, scalable vaccine manufacturing workforce training that can also be leveraged to develop company-specific training.
Login to the NIIMBL member portal to access more, including:
Not yet a member? Learn more about which level of NIIMBL membership is right for you and your organization.
Massachusetts Institute of Technology
Massachusetts Life Sciences Center
Merck Sharp & Dohme LLC
Quincy College
Sanofi
